| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
|
7,661 |
7,310 |
$657K |
| 99214 |
|
11,414 |
10,697 |
$358K |
| 93000 |
|
6,685 |
6,167 |
$100K |
| J2785 |
Injection, regadenoson, 0.1 mg |
386 |
350 |
$44K |
| 99204 |
|
531 |
496 |
$40K |
| 93296 |
|
2,127 |
2,034 |
$30K |
| 93295 |
|
517 |
508 |
$16K |
| 93016 |
|
891 |
851 |
$15K |
| 99213 |
|
649 |
618 |
$15K |
| 93017 |
|
320 |
295 |
$10K |
| 93294 |
|
507 |
490 |
$8K |
| 99215 |
Prolong outpt/office vis |
156 |
143 |
$6K |
| 78452 |
|
31 |
28 |
$6K |
| 93018 |
|
471 |
446 |
$6K |
| 99203 |
|
67 |
63 |
$4K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
87 |
85 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
30 |
27 |
$3K |
| 99152 |
|
297 |
265 |
$3K |
| 93015 |
|
25 |
25 |
$2K |
| 93970 |
|
13 |
13 |
$2K |
| 93227 |
|
27 |
27 |
$806.86 |
| 93298 |
|
50 |
49 |
$724.52 |
| 93308 |
|
12 |
12 |
$377.16 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
35 |
32 |
$315.57 |
| 93297 |
|
14 |
14 |
$81.45 |
| 1124F |
|
13 |
13 |
$0.00 |